Therefore, several recent studies have focused on indirect inhibition of oncogenic MYC activity using a synthetic lethal approach in targeting drugable proteins that are essential for the viability of MYC activated tumor cells but not for cells without MYC activation (a synthetic lethal approach). This evidence concerns the gene MYC and neoplasm.